Literature DB >> 11498411

Diffusion-weighted MR imaging after angioplasty or angioplasty plus stenting of arteries supplying the brain.

H J Jaeger1, K D Mathias, R Drescher, E Hauth, G Bockisch, E Demirel, H M Gissler.   

Abstract

BACKGROUND AND
PURPOSE: There has been concern regarding the safety of revascularization procedures of vessels supplying the brain vessels because of the risk of cerebral embolization during the procedure. We have observed a high incidence of hyperintense lesions on diffusion-weighted MR images of the brain after stenting at the carotid bifurcation. The hypothesis of this study is that diffusion-weighted MR imaging of the brain can reveal new diffusion abnormalities after angioplasty or angioplasty plus stenting of arteries supplying the brain, other than at the carotid bifurcation. Therefore, we prospectively obtained diffusion-weighted MR images of the brain before and after such revascularization procedures.
METHODS: Thirty-seven revascularization procedures were performed in 32 patients. Eleven interventions were performed at the distal internal carotid artery, two at the external carotid artery, two at the common carotid artery, five at the innominate artery, five at the vertebral artery, and 12 at the proximal subclavian artery. Diffusion-weighted MR imaging of the brain was performed before and 24 hours after the procedures.
RESULTS: After eight (22%) of 37 procedures, new hyperintensities were visible on the diffusion-weighted MR images. With six of these eight procedures, the hyperintensities occurred in the vascular territory supplied by the treated vessel. In total, 35 new cerebral lesions could be seen, 33 (94%) of which occurred in the vascular territory supplied by the treated vessel. None of the patients in whom new diffusion abnormalities were found had new neurologic symptoms or deficits. No new lesions could be seen after procedures at the subclavian artery.
CONCLUSION: Revascularization procedures of arteries supplying the brain were associated with new lesions on the diffusion-weighted MR images of the brain after 22% of the procedures, provided that MR imaging could be performed, indicating the occurrence of cerebral microemboli during such procedures. Diffusion-weighted MR imaging of the brain can be used as a tool to assess the impact of modifications of procedural technique and/or the use of cerebral protection devices on the occurrence of such lesions.

Entities:  

Mesh:

Year:  2001        PMID: 11498411      PMCID: PMC7975201     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  29 in total

1.  Subclavian artery angioplasty and the origin of the vertebral artery.

Authors:  J J Vitek
Journal:  Radiology       Date:  1989-02       Impact factor: 11.105

2.  Efficacy of a filter device in the prevention of embolic events during carotid angioplasty and stenting: An ex vivo analysis.

Authors:  T Ohki; G S Roubin; F J Veith; S S Iyer; E Brady
Journal:  J Vasc Surg       Date:  1999-12       Impact factor: 4.268

3.  How to measure carotid stenosis.

Authors:  A J Fox
Journal:  Radiology       Date:  1993-02       Impact factor: 11.105

4.  Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images.

Authors:  J H Burdette; A D Elster; P E Ricci
Journal:  Radiology       Date:  1999-08       Impact factor: 11.105

5.  Stent placement versus percutaneous transluminal angioplasty of human carotid arteries in cadavers in situ: distal embolization and findings at intravascular US, MR imaging and histopathologic analysis.

Authors:  H I Manninen; H T Räsänen; R L Vanninen; P Vainio; M Hippeläinen; V M Kosma
Journal:  Radiology       Date:  1999-08       Impact factor: 11.105

6.  Incidence of postangiographic abnormalities revealed by diffusion-weighted MR imaging.

Authors:  P M Britt; J E Heiserman; R M Snider; H A Shill; C R Bird; R C Wallace
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

7.  Silent embolism in diagnostic cerebral angiography and neurointerventional procedures: a prospective study.

Authors:  M Bendszus; M Koltzenburg; R Burger; M Warmuth-Metz; E Hofmann; L Solymosi
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

8.  Elective stenting of the extracranial carotid arteries.

Authors:  J S Yadav; G S Roubin; S Iyer; J Vitek; P King; W D Jordan; W S Fisher
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

9.  Carotid artery stenosis: treatment with protected balloon angioplasty and stent placement.

Authors:  J G Theron; G G Payelle; O Coskun; H F Huet; L Guimaraens
Journal:  Radiology       Date:  1996-12       Impact factor: 11.105

10.  Stenting in the carotid artery: initial experience in 110 patients.

Authors:  E B Diethrich; M Ndiaye; D B Reid
Journal:  J Endovasc Surg       Date:  1996-02
View more
  21 in total

1.  Carotid Stenting without Angioplasty and without Protection: The Advantages of a Less Invasive Procedure.

Authors:  M Leonardi; M Dall'olio; L Raffi; P Cenni; L Simonetti; R Marasco; F Giagnorio
Journal:  Interv Neuroradiol       Date:  2008-06-30       Impact factor: 1.610

2.  Diffusion-weighted magnetic resonance imaging in carotid angioplasty and stenting with balloon embolic protection devices.

Authors:  Fumio Asakura; Kenji Kawaguchi; Hiroshi Sakaida; Naoki Toma; Satoshi Matsushima; Keita Kuraishi; Hiroshi Tanemura; Yoichi Miura; Masayuki Maeda; Waro Taki
Journal:  Neuroradiology       Date:  2006-01-17       Impact factor: 2.804

Review 3.  Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention.

Authors:  John J Connors; David Sacks; Anthony J Furlan; Warren R Selman; Eric J Russell; Philip E Stieg; Mark N Hadley
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

4.  Risk factors for periprocedural complications in carotid artery stenting without filter protection: A serial diffusion-weighted MRI study.

Authors:  Hilmar Krapf; Thomas Nägele; Andreas Kastrup; Udo Bühring; Eckehard Grönewäller; Martin Skalej; Wilhelm Küker
Journal:  J Neurol       Date:  2005-10-01       Impact factor: 4.849

5.  Effects of age and symptom status on silent ischemic lesions after carotid stenting with and without the use of distal filter devices.

Authors:  A Kastrup; K Gröschel; T Nägele; A Riecker; F Schmidt; S Schnaudigel; U Ernemann
Journal:  AJNR Am J Neuroradiol       Date:  2007-12-07       Impact factor: 3.825

6.  Carotid intervention 3: the evidence for cerebral protection.

Authors:  Fabrizio Fanelli; Mario Bezzi; Emanuele Boatta; Roberto Passariello
Journal:  Semin Intervent Radiol       Date:  2007-06       Impact factor: 1.513

7.  The influence of carotid artery catheterization technique on the incidence of thromboembolism during carotid artery stenting.

Authors:  H J Kim; H J Lee; J H Yang; I S Yeo; J S Yi; I W Lee; S B Lee; S Y Ryu; J K Kim; P S Yang
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-01       Impact factor: 3.825

8.  MR and clinical follow-up of diffusion-weighted cerebral lesions after carotid artery stenting.

Authors:  Elke A M Hauth; Christian Jansen; Robert Drescher; Michael Schwartz; Michael Forsting; Horst J Jaeger; Klaus D Mathias
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

9.  New ischemic brain lesions on diffusion-weighted MRI after carotid artery stenting with filter protection: frequency and relationship with plaque morphology.

Authors:  D Stojanov; M Ilic; P Bosnjakovic; M Zivkovic; S Jolic; N Vukasinovic; A Ignjatovic; B Ilic; D Benedeto-Stojanov
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

10.  Cerebral ischemia after filter-protected carotid artery stenting is common and cannot be predicted by the presence of substantial amount of debris captured by the filter device.

Authors:  G Maleux; P Demaerel; E Verbeken; K Daenens; S Heye; F Van Sonhoven; A Nevelsteen; G Wilms
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.